Literature DB >> 35782810

Insulinoma-Accurate Preoperative Localization Is the Key to Management: An Initial Experience.

Ajay Sharma1, Peeyush Varshney2, Rajeev Kasliwal3, Anand Nagar4, Krishnavardhan Venkatatelikicherla1, Shashwat Sarin4, R P Choubey1, V K Kapoor4.   

Abstract

Insulinoma is the commonest functioning pancreatic neuroendocrine tumor. The only curative treatment is surgical excision after preoperative localization. A retrospective analysis of nine patients (February 2017-June 2020), 2 males and 7 females, was done for clinical presentation, biochemistry, localization methods, intraoperative findings, postoperative outcome, histopathology reports, and follow-up. Techniques for localization of the tumor were pancreatic protocol triple-phase multi-detector computed tomography (MDCT), endoscopic ultrasound (EUS), Ga 68 DOTANOC PET-CT, and Ga 68 NOTA-exendin-4 PET-CT (GLP1R scan). The mean age was 38 (range 20-68) years and mean duration of symptoms 34 (range 8-120) months, and symptoms of Whipple's triad were present in all cases after a supervised 72-h fast. MDCT localized tumor in 8/9 cases. EUS before MDCT in one patient had also localized tumors. Ga 68 DOTANOC PET-CT detected tumor in 2/4 patients. In one patient, MDCT or DOTANOC PET scan could not localize tumor; GLP1R scan localized tumor accurately. Two patients had associated MEN1 syndrome. All 9 patients underwent surgical resection (four open and five laparoscopic) of tumor-enucleation (3), distal pancreatectomy with splenectomy (3), and pancreatoduodenectomy (PD) (3). The last four procedures and all three enucleations were laparoscopic. Five patients developed postoperative pancreatic fistula (POPF), only one grade B which required percutaneous drain placement. One patient, who had initial open enucleation, developed hypoglycemia after 48 h; PD was performed. All patients were cured and all, except one (who died of upper GI bleed), were alive and disease-free during a mean follow-up of 26 (range 2-41) months. Preoperative localization of insulinoma is important and decides the outcome of surgery in terms of cure. MDCT can localize tumors in most patients; the last resort for localization is the GLP1R scan. Laparoscopic procedures are equally effective compared to open surgery. Considering the benign nature of the disease, enucleation is the procedure of choice.
© The Author(s), under exclusive licence to Indian Association of Surgical Oncology 2022.

Entities:  

Keywords:  Enucleation; Ga 68 NOTA-exendin-4 PET-CT; Insulinoma; Pancreatic neuroendocrine tumor

Year:  2022        PMID: 35782810      PMCID: PMC9240150          DOI: 10.1007/s13193-022-01534-6

Source DB:  PubMed          Journal:  Indian J Surg Oncol        ISSN: 0975-7651


  68 in total

Review 1.  Radiologic diagnosis and staging of pancreatic ductal adenocarcinoma.

Authors:  N C Balci; R C Semelka
Journal:  Eur J Radiol       Date:  2001-05       Impact factor: 3.528

2.  Well-differentiated pancreatic tumor/carcinoma: insulinoma.

Authors:  Wouter W de Herder; Bruno Niederle; Jean-Yves Scoazec; Stanislas Pauwels; Gunter Kloppel; Massimo Falconi; Dik J Kwekkeboom; Kjel Oberg; Barbro Eriksson; Bertram Wiedenmann; Guido Rindi; Dermot O'Toole; Diego Ferone
Journal:  Neuroendocrinology       Date:  2007-02-20       Impact factor: 4.914

Review 3.  Endoscopic tattooing of gastrointestinal and pancreatic lesions.

Authors:  Carmelo Luigiano; Francesco Ferrara; Carmela Morace; Benedetto Mangiavillano; Carlo Fabbri; Vincenzo Cennamo; Marco Bassi; Clara Virgilio; Pierluigi Consolo
Journal:  Adv Ther       Date:  2012-10-05       Impact factor: 3.845

4.  Assessing the short- and long-term outcomes after resection of benign insulinoma.

Authors:  Yi-Po Tsang; Brian Hung-Hin Lang; Tony Wai-Hung Shek
Journal:  ANZ J Surg       Date:  2014-10-23       Impact factor: 1.872

Review 5.  Insulinoma: pathophysiology, localization and management.

Authors:  Joyce J Shin; Phillip Gorden; Steven K Libutti
Journal:  Future Oncol       Date:  2010-02       Impact factor: 3.404

6.  Localization of Insulinoma Using 68Ga-DOTATATE PET/CT Scan.

Authors:  Pavel Nockel; Bruna Babic; Corina Millo; Peter Herscovitch; Dhaval Patel; Naris Nilubol; Samira M Sadowski; Craig Cochran; Phillip Gorden; Electron Kebebew
Journal:  J Clin Endocrinol Metab       Date:  2017-01-01       Impact factor: 5.958

7.  Localization of insulinomas to regions of the pancreas by intra-arterial stimulation with calcium.

Authors:  J L Doppman; R Chang; D L Fraker; J A Norton; H R Alexander; D L Miller; E Collier; M C Skarulis; P Gorden
Journal:  Ann Intern Med       Date:  1995-08-15       Impact factor: 25.391

Review 8.  Occult sporadic insulinoma: localization and surgical strategy.

Authors:  Bassam Abboud; Joe Boujaoude
Journal:  World J Gastroenterol       Date:  2008-02-07       Impact factor: 5.742

9.  Endoscopic ultrasonography (EUS) in the localization of insulinoma.

Authors:  Rasoul Sotoudehmanesh; Anooshirvan Hedayat; Nahid Shirazian; Shadi Shahraeeni; Sanaz Ainechi; Fatemeh Zeinali; Shadi Kolahdoozan
Journal:  Endocrine       Date:  2007-06       Impact factor: 3.633

10.  Surgery for benign insulinoma: an international review.

Authors:  M Rothmund; L Angelini; L M Brunt; J R Farndon; G Geelhoed; D Grama; C Herfarth; E L Kaplan; F Largiader; F Morino
Journal:  World J Surg       Date:  1990 May-Jun       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.